Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.05
VWR's Cash-to-Debt is ranked lower than
96% of the 244 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.13 vs. VWR: 0.05 )
Ranked among companies with meaningful Cash-to-Debt only.
VWR' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.05  Med: 0.06 Max: 0.12
Current: 0.05
0.05
0.12
Equity-to-Asset 0.31
VWR's Equity-to-Asset is ranked lower than
86% of the 228 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 0.61 vs. VWR: 0.31 )
Ranked among companies with meaningful Equity-to-Asset only.
VWR' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.08  Med: 0.27 Max: 0.31
Current: 0.31
0.08
0.31
Debt-to-Equity 1.37
VWR's Debt-to-Equity is ranked lower than
90% of the 150 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 0.35 vs. VWR: 1.37 )
Ranked among companies with meaningful Debt-to-Equity only.
VWR' s Debt-to-Equity Range Over the Past 10 Years
Min: 1.34  Med: 1.57 Max: 7.75
Current: 1.37
1.34
7.75
Debt-to-EBITDA 4.99
VWR's Debt-to-EBITDA is ranked lower than
86% of the 111 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.62 vs. VWR: 4.99 )
Ranked among companies with meaningful Debt-to-EBITDA only.
VWR' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 3.94  Med: 4.54 Max: 9.27
Current: 4.99
3.94
9.27
Interest Coverage 3.96
VWR's Interest Coverage is ranked lower than
83% of the 163 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 60.25 vs. VWR: 3.96 )
Ranked among companies with meaningful Interest Coverage only.
VWR' s Interest Coverage Range Over the Past 10 Years
Min: 1.25  Med: 1.62 Max: 3.96
Current: 3.96
1.25
3.96
Piotroski F-Score: 6
Altman Z-Score: 1.87
Beneish M-Score: -2.49
WACC vs ROIC
7.27%
5.60%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % 6.84
VWR's Operating Margin % is ranked higher than
62% of the 229 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 2.14 vs. VWR: 6.84 )
Ranked among companies with meaningful Operating Margin % only.
VWR' s Operating Margin % Range Over the Past 10 Years
Min: 6.07  Med: 6.69 Max: 7.41
Current: 6.84
6.07
7.41
Net Margin % 3.12
VWR's Net Margin % is ranked higher than
59% of the 228 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -0.44 vs. VWR: 3.12 )
Ranked among companies with meaningful Net Margin % only.
VWR' s Net Margin % Range Over the Past 10 Years
Min: 0.09  Med: 2.34 Max: 3.57
Current: 3.12
0.09
3.57
ROE % 9.38
VWR's ROE % is ranked higher than
67% of the 222 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -1.01 vs. VWR: 9.38 )
Ranked among companies with meaningful ROE % only.
VWR' s ROE % Range Over the Past 10 Years
Min: -20.54  Med: 10.47 Max: 13.96
Current: 9.38
-20.54
13.96
ROA % 2.82
VWR's ROA % is ranked higher than
64% of the 244 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -2.54 vs. VWR: 2.82 )
Ranked among companies with meaningful ROA % only.
VWR' s ROA % Range Over the Past 10 Years
Min: 0.14  Med: 3 Max: 3.16
Current: 2.82
0.14
3.16
ROC (Joel Greenblatt) % 42.20
VWR's ROC (Joel Greenblatt) % is ranked higher than
79% of the 242 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -5.64 vs. VWR: 42.20 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
VWR' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 33.71  Med: 54.4 Max: 66.35
Current: 42.2
33.71
66.35
3-Year Revenue Growth Rate -90.60
VWR's 3-Year Revenue Growth Rate is ranked lower than
97% of the 180 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 5.10 vs. VWR: -90.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
VWR' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: -90.7 Max: -90.6
Current: -90.6
3-Year EBITDA Growth Rate -90.10
VWR's 3-Year EBITDA Growth Rate is ranked lower than
100% of the 173 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 6.90 vs. VWR: -90.10 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
VWR' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: -90.1 Max: -89.9
Current: -90.1
GuruFocus has detected 4 Warning Signs with VWR Corp VWR.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» VWR's 30-Y Financials

Financials (Next Earnings Date: 2017-11-03)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

VWR Guru Trades in Q3 2016

Robert Olstein 168,239 sh (New)
Jim Simons 366,300 sh (+76.70%)
Columbia Wanger 3,094,606 sh (-35.37%)
Paul Tudor Jones 13,910 sh (-63.16%)
» More
Q4 2016

VWR Guru Trades in Q4 2016

Joel Greenblatt 21,107 sh (New)
Robert Olstein 432,387 sh (+157.01%)
Paul Tudor Jones 15,943 sh (+14.62%)
Columbia Wanger 2,393,320 sh (-22.66%)
Jim Simons 214,400 sh (-41.47%)
» More
Q1 2017

VWR Guru Trades in Q1 2017

Joel Greenblatt 46,582 sh (+120.69%)
Robert Olstein 506,824 sh (+17.22%)
Jim Simons 186,000 sh (-13.25%)
Paul Tudor Jones 11,611 sh (-27.17%)
Columbia Wanger 1,390,129 sh (-41.92%)
» More
Q2 2017

VWR Guru Trades in Q2 2017

Mario Gabelli 62,600 sh (New)
David Dreman 1,196 sh (New)
John Paulson 2,675,200 sh (New)
Jim Simons 836,700 sh (+349.84%)
Joel Greenblatt Sold Out
Paul Tudor Jones Sold Out
Columbia Wanger Sold Out
Robert Olstein 451,124 sh (-10.99%)
» More
» Details

Insider Trades

Latest Guru Trades with VWR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
John Paulson 2017-06-30 New Buy1.2%$27.23 - $34.05 $ 33.136%2,675,200
Robert Olstein 2017-06-30 Reduce -10.99%0.2%$27.23 - $34.05 $ 33.136%451,124
Mario Gabelli 2017-06-30 New Buy0.01%$27.23 - $34.05 $ 33.136%62,600
David Dreman 2017-06-30 New Buy0.02%$27.23 - $34.05 $ 33.136%1,196
Joel Greenblatt 2017-06-30 Sold Out 0.02%$27.23 - $34.05 $ 33.136%0
Robert Olstein 2017-03-31 Add 17.22%0.27%$24.8 - $28.55 $ 33.1324%506,824
Joel Greenblatt 2017-03-31 Add 120.69%0.01%$24.8 - $28.55 $ 33.1324%46,582
Robert Olstein 2016-12-31 Add 157.01%0.86%$24.75 - $28.44 $ 33.1325%432,387
Joel Greenblatt 2016-12-31 New Buy0.01%$24.75 - $28.44 $ 33.1325%21,107
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Diagnostics & Research » Diagnostics & Research    NAICS: 621511    SIC: 8099
Compare:NYSE:ALR, NAS:PRXL, XTER:AFX, NAS:BRKR, NAS:PRAH, MIL:DIA, NYSE:CRL, NAS:INCR, NAS:EXAS, BSP:FLRY3, NAS:NEOG, SHSE:603658, NAS:DXCM, BSP:DASA3, TSE:4544, NAS:ICLR, NAS:MYGN, XTER:SRT3, SZSE:300244, SZSE:300463 » details
Traded in other countries:VW1.Germany,
Headquarter Location:USA
VWR Corp is a distributor of laboratory products mainly in the United States and to a lesser extent in Europe. Its products include chemicals, reagents, consumables, durable products, and scientific instruments.

VWR Corp operates in the healthcare sector based in the United States. It primarily offers laboratory products mainly in the American market, while distributing a minor share abroad. It provides a suite of products such as chemicals, reagents, consumables, durable products and scientific equipment and instruments to customers in the life science, general research and applied markets, including the biopharma, agricultural, chemical, environmental, food and beverage, healthcare, microelectronic, and petrochemical industries.

Ratios

vs
industry
vs
history
PE Ratio 30.68
VWR's PE Ratio is ranked higher than
59% of the 105 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 34.50 vs. VWR: 30.68 )
Ranked among companies with meaningful PE Ratio only.
VWR' s PE Ratio Range Over the Past 10 Years
Min: 19.63  Med: 26.29 Max: 72.26
Current: 30.68
19.63
72.26
Forward PE Ratio 16.98
VWR's Forward PE Ratio is ranked higher than
88% of the 33 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 23.26 vs. VWR: 16.98 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 30.68
VWR's PE Ratio without NRI is ranked higher than
61% of the 108 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 36.88 vs. VWR: 30.68 )
Ranked among companies with meaningful PE Ratio without NRI only.
VWR' s PE Ratio without NRI Range Over the Past 10 Years
Min: 19.63  Med: 26.29 Max: 72.46
Current: 30.68
19.63
72.46
Price-to-Owner-Earnings 27.68
VWR's Price-to-Owner-Earnings is ranked higher than
60% of the 73 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 34.21 vs. VWR: 27.68 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
VWR' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 27.44  Med: 27.58 Max: 27.77
Current: 27.68
27.44
27.77
PB Ratio 2.68
VWR's PB Ratio is ranked higher than
67% of the 223 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.97 vs. VWR: 2.68 )
Ranked among companies with meaningful PB Ratio only.
VWR' s PB Ratio Range Over the Past 10 Years
Min: 2.2  Med: 2.59 Max: 2.94
Current: 2.68
2.2
2.94
PS Ratio 0.96
VWR's PS Ratio is ranked higher than
89% of the 217 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.68 vs. VWR: 0.96 )
Ranked among companies with meaningful PS Ratio only.
VWR' s PS Ratio Range Over the Past 10 Years
Min: 0.69  Med: 0.81 Max: 0.96
Current: 0.96
0.69
0.96
Price-to-Free-Cash-Flow 24.63
VWR's Price-to-Free-Cash-Flow is ranked higher than
53% of the 74 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 24.99 vs. VWR: 24.63 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
VWR' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0.27  Med: 18.51 Max: 27.86
Current: 24.63
0.27
27.86
Price-to-Operating-Cash-Flow 18.73
VWR's Price-to-Operating-Cash-Flow is ranked higher than
55% of the 92 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 20.00 vs. VWR: 18.73 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
VWR' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0.15  Med: 14.46 Max: 21.7
Current: 18.73
0.15
21.7
EV-to-EBIT 20.99
VWR's EV-to-EBIT is ranked higher than
65% of the 116 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 27.52 vs. VWR: 20.99 )
Ranked among companies with meaningful EV-to-EBIT only.
VWR' s EV-to-EBIT Range Over the Past 10 Years
Min: 11  Med: 16.5 Max: 21.3
Current: 20.99
11
21.3
EV-to-EBITDA 14.51
VWR's EV-to-EBITDA is ranked higher than
69% of the 131 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 21.06 vs. VWR: 14.51 )
Ranked among companies with meaningful EV-to-EBITDA only.
VWR' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.7  Med: 11.8 Max: 14.6
Current: 14.51
8.7
14.6
EV-to-Revenue 1.42
VWR's EV-to-Revenue is ranked higher than
88% of the 227 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.94 vs. VWR: 1.42 )
Ranked among companies with meaningful EV-to-Revenue only.
VWR' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.1  Med: 1.2 Max: 1.4
Current: 1.42
1.1
1.4
Current Ratio 1.19
VWR's Current Ratio is ranked lower than
83% of the 234 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 2.51 vs. VWR: 1.19 )
Ranked among companies with meaningful Current Ratio only.
VWR' s Current Ratio Range Over the Past 10 Years
Min: 1.18  Med: 1.51 Max: 1.82
Current: 1.19
1.18
1.82
Quick Ratio 0.76
VWR's Quick Ratio is ranked lower than
90% of the 234 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 2.14 vs. VWR: 0.76 )
Ranked among companies with meaningful Quick Ratio only.
VWR' s Quick Ratio Range Over the Past 10 Years
Min: 0.76  Med: 1.02 Max: 1.22
Current: 0.76
0.76
1.22
Days Inventory 52.62
VWR's Days Inventory is ranked higher than
59% of the 194 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 80.37 vs. VWR: 52.62 )
Ranked among companies with meaningful Days Inventory only.
VWR' s Days Inventory Range Over the Past 10 Years
Min: 20.33  Med: 44.26 Max: 52.62
Current: 52.62
20.33
52.62
Days Sales Outstanding 53.99
VWR's Days Sales Outstanding is ranked higher than
63% of the 196 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 67.49 vs. VWR: 53.99 )
Ranked among companies with meaningful Days Sales Outstanding only.
VWR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.68  Med: 49.29 Max: 53.99
Current: 53.99
48.68
53.99
Days Payable 55.89
VWR's Days Payable is ranked lower than
53% of the 179 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 63.34 vs. VWR: 55.89 )
Ranked among companies with meaningful Days Payable only.
VWR' s Days Payable Range Over the Past 10 Years
Min: 50.82  Med: 54.33 Max: 56.46
Current: 55.89
50.82
56.46

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -995.90
VWR's 3-Year Average Share Buyback Ratio is ranked lower than
100% of the 175 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -7.50 vs. VWR: -995.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
VWR' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -995.9  Med: -995.3 Max: 0
Current: -995.9
-995.9
0

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 1.18
VWR's Price-to-Median-PS-Value is ranked lower than
60% of the 192 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.01 vs. VWR: 1.18 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
VWR' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.9  Med: 1.01 Max: 1.18
Current: 1.18
0.9
1.18
Earnings Yield (Greenblatt) % 4.76
VWR's Earnings Yield (Greenblatt) % is ranked higher than
83% of the 246 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -0.72 vs. VWR: 4.76 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
VWR' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 4.7  Med: 6 Max: 9.1
Current: 4.76
4.7
9.1

More Statistics

Revenue (TTM) (Mil) $4,580.80
EPS (TTM) $ 1.08
Beta1.18
Short Percentage of Float1.31%
52-Week Range $24.42 - 37.25
Shares Outstanding (Mil)131.84

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 4,704 4,860 4,967
EPS ($) 1.86 1.95 2.05
EPS without NRI ($) 1.86 1.95 2.05
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyY
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}